Toronto, Ontario – February 24, 2014 – Vida Cannabis Corp. (“Vida Cannabis”) is pleased to announce the appointment of Dr. Michael Stocker to its board of directors. Dr. Stocker joins current directors J. Gregory Wilson, CEO, and Christine Fard, Chief Legal Counsel.

Michael Stocker, PhD, is an entrepreneur from Switzerland and a leading software, Internet and e-commerce specialist for Latin America. He has held executive positions in several companies, notably as Manager of FUNDES International, the leading business incubator in Latin America, as well as Regional Manager for PROPEL Colombia, a foundation to promote cleaner production technologies. Prior to his involvement in business promotion he worked for the Boston Consulting Group (BCG), in its offices in Mexico, Spain and Switzerland, in connection with the development of business strategies and management structure for a number of worldwide active corporations and companies, among them several Fortune 500 companies.

The consulting and technology branch of his own company, the Stocker Group, founded in 2004, has offices in five countries and offers Risk and Knowledge Management to some of the world’s biggest international organizations, including the United Nations, the World Bank and several governments including the USA, Switzerland and several countries in Latin America. Since 2008 Dr. Stocker has initiated and invested in several ventures, among them a company he founded in 2010 (Medtechtrade) in the medical equipment sector, which offers second-hand medical equipment from hospitals in Europe to hospitals on all continents in need of such equipment. He is also a shareholder and investor in mining and real estate companies in Peru and Colombia, as well as CEO of US biotech company Biologix Hair Inc.

Dr. Stocker has been invited as a speaker to several international conferences and has previously been retained as an adviser and consultant by the Inter-American Development Bank, the United Nations Industrial Development Organization (UNIDO), the Swiss State Secretariat for Economic Affairs (SECO), the World Bank’s International Finance Corporation (IFC), the Organization of American States (OAS) and the government of Colombia, as well as several private companies.

Dr. Stocker holds a PhD in Economics from the University of St. Gallen, Switzerland and an MBA from the Community of European Management Schools (CEMS). He has lived and worked in Latin America, chiefly in Chile, Colombia and Costa Rica, since 1993.

About Vida Cannabis Corp.

Vida Cannabis Corp. (“Vida Cannabis”) is focused on developing a dominant production footprint in the rapidly developing global marketplace for the legal use of medicinal and recreational marijuana.

Initial operations are focused on the Canadian market where Health Canada has established national guidelines enabling best-in-class producers to acquire commercial production licenses under the Marihuana for Medical Purposes Regulations.

Vida Cannabis continues to evaluate additional potential markets as regulatory bodies around the world pass legislation enabling the production and distribution of medicinal or recreational marijuana.

On behalf of the board,

Greg Wilson – Director & CEO
Vida Cannabis Corp.

Investor Relations
Toll free +1 800 593 1585
Direct: +1 647 560 4482
Email: InvestorServices@VidaCannabis.com
Web: VidaCannabis.com

Disclaimer
This announcement does not constitute or form part of, and shall under no circumstances be considered as, an offer to sell, a solicitation to purchase, or advice on investments in any securities of Vida Cannabis Corp. (“Vida Cannabis”). Offers and solicitations shall be expressly identified as such and made in compliance with applicable securities laws. This announcement is for information purposes only. It should not be relied upon as a basis for investment decisions. You should consult with your own investment, accounting, legal and tax advisers to evaluate independently the risks, consequences and suitability of any investments you are considering. Whilst the information provided here is believed to be reliable, it cannot be guaranteed. It may contain forward-looking statements made by or on behalf of Vida Cannabis about its business or financial objectives, position, strategies or expectations. Such forward-looking statements may be identified by words such as, or similar to, “intends,” “anticipates,” “believes,” “expects” and “hopes” and includes, without limitation, the development of production facilities, approval from regulatory authorities and the ability for Vida Cannabis to obtain adequate financing to meet its business objectives. These statements involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated. The statements in this announcement do not guarantee future performance. Vida Cannabis does not undertake any obligation to update any information provided in this announcement. In Canada, Vida Cannabis (Canada) Ltd., a wholly owned subsidiary of Vida Cannabis, must obtain approval from Health Canada in order to operate as a licensed commercial producer under the Marihuana for Medical Purposes Regulations. Vida Cannabis makes no representations or warranties that it will receive Health Canada approval.

Leave a Comment